PF-00356231 hydrochloride
≥99%
- Product Code: 101926
CAS:
820223-77-6
| Molecular Weight: | 464.96 g./mol | Molecular Formula: | C₂₅H₂₁ClN₂O₃S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
PF-00356231 hydrochloride is primarily utilized in the field of pharmaceutical research and development, particularly in the study of neurological disorders. It acts as a potent and selective antagonist for the kappa opioid receptor (KOR), making it a valuable tool for investigating the role of KOR in pain management, mood regulation, and addiction. Researchers use this compound to explore potential therapeutic applications for conditions such as chronic pain, depression, and substance abuse disorders. Its specificity allows for a better understanding of the receptor's function and the development of targeted treatments with fewer side effects. Additionally, it is employed in preclinical studies to evaluate the efficacy and safety of new drugs targeting the kappa opioid receptor pathway.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿13,950.00 |
+
-
|
| 0.005 | 10-20 days | ฿42,300.00 |
+
-
|
| 0.010 | 10-20 days | ฿72,000.00 |
+
-
|
PF-00356231 hydrochloride
PF-00356231 hydrochloride is primarily utilized in the field of pharmaceutical research and development, particularly in the study of neurological disorders. It acts as a potent and selective antagonist for the kappa opioid receptor (KOR), making it a valuable tool for investigating the role of KOR in pain management, mood regulation, and addiction. Researchers use this compound to explore potential therapeutic applications for conditions such as chronic pain, depression, and substance abuse disorders. Its specificity allows for a better understanding of the receptor's function and the development of targeted treatments with fewer side effects. Additionally, it is employed in preclinical studies to evaluate the efficacy and safety of new drugs targeting the kappa opioid receptor pathway.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :